Role of CD44 as a marker of cancer stem cells in head and neck cancer
Serena Trapasso, Eugenia AllegraOtolaryngology – Head and Neck Surgery, University Magna Graecia of Catanzaro, Catanzaro, ItalyAbstract: In recent years, many studies have shown that some types of tumors are characterized by the presence of cells with stem-like characteristics, called...
Saved in:
Main Authors: | Trapasso S, Allegra E |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/d693ae093c7844839dba85f47659d35d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CD44-Targeted Magnetic Nanoparticles Kill Head And Neck Squamous Cell Carcinoma Stem Cells In An Alternating Magnetic Field
by: Su Z, et al.
Published: (2019) -
MiR-520b as a novel molecular target for suppressing stemness phenotype of head-neck cancer by inhibiting CD44
by: Ya-Ching Lu, et al.
Published: (2017) -
Cetuximab: its unique place in head and neck cancer treatment
by: Specenier P, et al.
Published: (2013) -
The contribution of cetuximab in the treatment of recurrent and/or metastatic head and neck cancer
by: Mohamedtaki A Tejani, et al.
Published: (2010) -
The Role of B Cells in Head and Neck Cancer
by: Niki Gavrielatou, et al.
Published: (2021)